{
    "organizations": [],
    "uuid": "68dd0cdde3c4383f0801fe00aa8e415c16092c8d",
    "author": "Reuters Editorial",
    "url": "https://www.reuters.com/article/brief-indivior-says-sublocade-made-avail/brief-indivior-says-sublocade-made-available-in-u-s-idUSFWN1QJ0OH",
    "ord_in_thread": 0,
    "title": "Indivior Says Sublocade Made Available In U.S​",
    "locations": [],
    "highlightText": "",
    "language": "english",
    "persons": [],
    "text": "March 1 (Reuters) - Indivior Plc:\n* ‍INDIVIOR ANNOUNCES SUBLOCADET AVAILABLE IN US * ‍SUBLOCADE IS NOW AVAILABLE AS FIRST AND ONLY MONTHLY INJECTABLE BUPRENORPHINE IN U.S. TO TREAT PATIENTS WITH MODERATE TO SEVERE OPIOID USE DISORDER​​ Source text for Eikon:\n ",
    "published": "2018-03-01T21:03:00.000+02:00",
    "crawled": "2018-03-02T20:24:20.013+02:00",
    "highlightTitle": "",
    "preprocessed_text": [
        "march",
        "reuters",
        "indivior",
        "plc",
        "announces",
        "sublocadet",
        "available",
        "u",
        "available",
        "first",
        "monthly",
        "injectable",
        "buprenorphine",
        "treat",
        "patient",
        "moderate",
        "severe",
        "opioid",
        "use",
        "source",
        "text",
        "eikon"
    ]
}